Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Emergent Biosolutions (GB:0IGA)
LSE:0IGA
RESEARCH TOOLSreports
Holding GB:0IGA?
Track your performance easily
0IGA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.48 - $15.10
Previous Close$7.19
Volume18.27K
Average Volume (3M)43.00K
Market Cap
$377.60M
Enterprise Value$1.17B
Total Cash (Recent Filing)$69.70M
Total Debt (Recent Filing)$862.20M
Price to Earnings (P/E)―
Beta2.86
Next Earnings
Nov 06, 2024EPS Estimate
-$0.09Last Dividend Ex-Date
Aug 01, 2016Dividend YieldN/A
Share Statistics
EPS (TTM)-11.25
Shares Outstanding52,906,624
10 Day Avg. Volume12,694
30 Day Avg. Volume43,003
Standard Deviation0.33
R-Squared0.00955
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)0.99
Price to Sales (P/S)0.34
Price to Cash Flow (P/CF)2.00
P/FCF Ratio2.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.07
Enterprise Value/Gross Profit3.68
Enterprise Value/Ebitda-3.07
Forecast
1Y Price Target
$12.00Price Target Upside77.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Emergent Biosolutions News
Options Prices
Currently, No data available
---
Ownership Overview
42.95% Insiders
24.83% Mutual Funds
26.76% Other Institutional Investors
5.46% Public Companies and
Individual Investors
0IGA FAQ
What was Emergent Biosolutions’s price range in the past 12 months?
Emergent Biosolutions lowest share price was $1.48 and its highest was $15.10 in the past 12 months.
What is Emergent Biosolutions’s market cap?
Currently, no data Available
When is Emergent Biosolutions’s upcoming earnings report date?
Emergent Biosolutions’s upcoming earnings report date is Nov 06, 2024 which is in 46 days.
How were Emergent Biosolutions’s earnings last quarter?
Emergent Biosolutions released its earnings results on Aug 06, 2024. The company reported -$2.32 earnings per share for the quarter, missing the consensus estimate of -$1.135 by -$1.185.
Is Emergent Biosolutions overvalued?
According to Wall Street analysts Emergent Biosolutions’s price is currently Undervalued.
Does Emergent Biosolutions pay dividends?
Emergent Biosolutions pays a Notavailable dividend of $1.85 which represents an annual dividend yield of N/A. See more information on Emergent Biosolutions dividends here
What is Emergent Biosolutions’s EPS estimate?
Emergent Biosolutions’s EPS estimate is -$0.09.
How many shares outstanding does Emergent Biosolutions have?
Emergent Biosolutions has 54,019,962 shares outstanding.
What happened to Emergent Biosolutions’s price movement after its last earnings report?
Emergent Biosolutions reported an EPS of -$2.32 in its last earnings report, missing expectations of -$1.135. Following the earnings report the stock price went down -43.411%.
Which hedge fund is a major shareholder of Emergent Biosolutions?
Among the largest hedge funds holding Emergent Biosolutions’s share is Aristeia Capital LLC. It holds Emergent Biosolutions’s shares valued at 642K.
---
Emergent Biosolutions Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (77.78% Upside)
$12.00 (77.78% Upside)
Blogger Sentiment
Bullish
GB:0IGA Sentiment 100%
Sector Average 71%
Sector Average 71%
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.90%
12-Months-Change
Fundamentals
Return on Equity
-87.44%
Trailing 12-Months
Asset Growth
-30.54%
Trailing 12-Months
Company Description
Emergent Biosolutions
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.
---
0IGA Company Deck
---
0IGA Earnings Call
Q2 2024
0:00 / 0:00
---
0IGA Stock 12 Month Forecast
Average Price Target
$12.00
▲(77.78% Upside)
Technical Analysis
Emergent Biosolutions
―
SIGA Technologies
―
ADMA Biologics
―
Inovio Pharmaceuticals
―
Dynavax
―
Best Analysts Covering 0IGA
1 Year
1 Year Success Rate
5/20 ratings generated profit
1 Year Average Return
-9.42%
initiated a buy rating last month
Copying Brandon Folkes's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -9.42% per trade.
---